Showing results (181-190 of 776) with videos related to
Sort By:
Pageof 78
JAMA|May 18, 1999
Malondialdehyde-modified LDL as a marker of acute coronary syndromesP Holvoet, D Collen, F Van de WerfEuropean Journal of Biochemistry|January 15, 1993
Interaction of staphylokinase with different molecular forms of plasminogenH R Lijnen, B Van Hoef, D CollenCirculation|July 15, 1996
Recombinant staphylokinase variants with altered immunoreactivity. II: Thrombolytic properties and antibody inductionD Collen, H Moreau, L Stockx, et al.Thrombosis and Haemostasis|August 1, 1994
On the immunogenicity of recombinant staphylokinase in patients and in animal modelsS M Vanderschueren, J M Stassen, D CollenThrombosis and Haemostasis|August 30, 1983
Interaction of heparin with histidine-rich glycoprotein and with antithrombin IIIH R Lijnen, B van Hoef, D CollenThe Journal of Laboratory and Clinical Medicine|February 1, 1983
Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assayD C Rijken, I Juhan-Vague, D CollenThrombosis and Haemostasis|August 31, 1984
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeysD Collen, F De Cock, H R LijnenJournal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
High resolution mapping of the B cell epitopes of staphylokinase in humans using negative selection of a phage-displayed antigen libraryS Jenné, K Brepoels, D Collen, et al.Biochimica Et Biophysica Acta|June 19, 2001
Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1H R Lijnen, B Van Hoef, D CollenPageof 78